{
    "medicine_id": "f9a272ccf061c6613905048150e6a6bb1dd8dfae",
    "platform_id": "DB12598",
    "metadata": {
        "name": "Re action E Powder",
        "composition": "Nafamostat",
        "clinical_particulars": {
            "therapeutic_indications": "Used as an anticoagulant in patients with disseminative blood vessel coagulation hemorrhagic lesions and hemorrhagic tendencies It prevents blood clot formation during extracorporeal circulation in patients undergoing continuous renal replacement therapy and extra corporeal membrane oxygenation",
            "contraindications": {
                "disease": "Reported incidences of agranulocytosis hyperkalemia and anaphylaxis The use of nafamostat has been reported to cause cardiac arrest in patients receiving dialysis due to a sudden change in the patient s condition such as dyspnea A study suggests that the drug and its metabolites may inhibit the amiloride sensitive sodium Na conductance at the collecting ducts resulting in an inhibition of K secretion and hyperkalemia A19240 Reported LD50 value from intravenous administration in rats is 16 4mg kg",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Nafamostat is a fast acting proteolytic inhibitor used during hemodialysis to prevent the proteolysis of fibrinogen into fibrin by competitively inhibiting several serine proteases including thrombin It improves acute pancreatitis and prevents blood clot formation during extracorporeal circulation and has an anti inflammatory effect in vitro A study suggets that nafamostat has a neuroprotective role during ischemia induced brain injury from antithrombin activity A19228",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB06605",
                        "description": "Apixaban may increase the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB06695",
                        "description": "Dabigatran etexilate may increase the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01609",
                        "description": "The risk or severity of gastrointestinal bleeding can be increased when Nafamostat is combined with Deferasirox"
                    },
                    {
                        "drugbank-id": "DB01586",
                        "description": "The risk or severity of bleeding and bruising can be increased when Nafamostat is combined with Ursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB02123",
                        "description": "The risk or severity of bleeding and bruising can be increased when Nafamostat is combined with Glycochenodeoxycholic Acid"
                    },
                    {
                        "drugbank-id": "DB02659",
                        "description": "The risk or severity of bleeding and bruising can be increased when Nafamostat is combined with Cholic Acid"
                    },
                    {
                        "drugbank-id": "DB02691",
                        "description": "The risk or severity of bleeding and bruising can be increased when Nafamostat is combined with Glycocholic acid"
                    },
                    {
                        "drugbank-id": "DB03619",
                        "description": "The risk or severity of bleeding and bruising can be increased when Nafamostat is combined with Deoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB04348",
                        "description": "The risk or severity of bleeding and bruising can be increased when Nafamostat is combined with Taurocholic acid"
                    },
                    {
                        "drugbank-id": "DB05990",
                        "description": "The risk or severity of bleeding and bruising can be increased when Nafamostat is combined with Obeticholic acid"
                    },
                    {
                        "drugbank-id": "DB06777",
                        "description": "The risk or severity of bleeding and bruising can be increased when Nafamostat is combined with Chenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB08833",
                        "description": "The risk or severity of bleeding and bruising can be increased when Nafamostat is combined with Taurochenodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB08834",
                        "description": "The risk or severity of bleeding and bruising can be increased when Nafamostat is combined with Tauroursodeoxycholic acid"
                    },
                    {
                        "drugbank-id": "DB08857",
                        "description": "The risk or severity of bleeding and bruising can be increased when Nafamostat is combined with Bamet UD2"
                    },
                    {
                        "drugbank-id": "DB11622",
                        "description": "The risk or severity of bleeding and bruising can be increased when Nafamostat is combined with Dehydrocholic acid"
                    },
                    {
                        "drugbank-id": "DB11789",
                        "description": "The risk or severity of bleeding and bruising can be increased when Nafamostat is combined with Hyodeoxycholic Acid"
                    },
                    {
                        "drugbank-id": "DB09075",
                        "description": "The risk or severity of bleeding can be increased when Edoxaban is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB09053",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Ibrutinib is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB08935",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Nafamostat is combined with Obinutuzumab"
                    },
                    {
                        "drugbank-id": "DB06228",
                        "description": "Nafamostat may increase the anticoagulant activities of Rivaroxaban"
                    },
                    {
                        "drugbank-id": "DB06206",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Nafamostat is combined with Sugammadex"
                    },
                    {
                        "drugbank-id": "DB09070",
                        "description": "Tibolone may increase the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00932",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Tipranavir is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00013",
                        "description": "Urokinase may increase the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00163",
                        "description": "Vitamin E may increase the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB09030",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01156",
                        "description": "The excretion of Nafamostat can be decreased when combined with Bupropion"
                    },
                    {
                        "drugbank-id": "DB01381",
                        "description": "The therapeutic efficacy of Nafamostat can be increased when used in combination with Ginkgo biloba"
                    },
                    {
                        "drugbank-id": "DB01181",
                        "description": "The risk or severity of bleeding can be increased when Ifosfamide is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The therapeutic efficacy of Nafamostat can be increased when used in combination with Quinine"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "The therapeutic efficacy of Nafamostat can be increased when used in combination with Quinidine"
                    },
                    {
                        "drugbank-id": "DB00675",
                        "description": "The risk or severity of bleeding can be increased when Tamoxifen is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00539",
                        "description": "The risk or severity of bleeding can be increased when Toremifene is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00806",
                        "description": "The therapeutic efficacy of Nafamostat can be increased when used in combination with Pentoxifylline"
                    },
                    {
                        "drugbank-id": "DB00686",
                        "description": "Pentosan polysulfate may increase the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00583",
                        "description": "The therapeutic efficacy of Nafamostat can be increased when used in combination with Levocarnitine"
                    },
                    {
                        "drugbank-id": "DB00255",
                        "description": "Diethylstilbestrol may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00269",
                        "description": "Chlorotrianisene may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00286",
                        "description": "Conjugated estrogens may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00977",
                        "description": "Ethinylestradiol may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01357",
                        "description": "Mestranol may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB04574",
                        "description": "Estrone sulfate may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB04575",
                        "description": "Quinestrol may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB07931",
                        "description": "Hexestrol may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB09317",
                        "description": "Synthetic Conjugated Estrogens A may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB09318",
                        "description": "Synthetic Conjugated Estrogens B may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB09369",
                        "description": "Polyestradiol phosphate may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB09381",
                        "description": "Esterified estrogens may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB11478",
                        "description": "Zeranol may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB11674",
                        "description": "Equol may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13143",
                        "description": "Methallenestril may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13386",
                        "description": "Epimestrol may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13418",
                        "description": "Moxestrol may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB15334",
                        "description": "Biochanin A may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB15335",
                        "description": "Formononetin may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00783",
                        "description": "Estradiol may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13952",
                        "description": "Estradiol acetate may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13953",
                        "description": "Estradiol benzoate may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13954",
                        "description": "Estradiol cypionate may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13956",
                        "description": "Estradiol valerate may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00655",
                        "description": "Estrone may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB04573",
                        "description": "Estriol may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB09211",
                        "description": "The risk or severity of adverse effects can be increased when Limaprost is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00159",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Icosapent is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00244",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00328",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00461",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Nabumetone is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00465",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00469",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Tenoxicam is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00482",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Celecoxib is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00500",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Tolmetin is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00533",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Rofecoxib is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00554",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Piroxicam is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00573",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Fenoprofen is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00580",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00586",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Diclofenac is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00605",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Sulindac is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00712",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00749",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Etodolac is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00784",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Mefenamic acid is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00788",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Naproxen is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00795",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Sulfasalazine is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00812",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Phenylbutazone is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00814",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Meloxicam is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00821",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Carprofen is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00861",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Diflunisal is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00936",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Salicylic acid is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00939",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Meclofenamic acid is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00991",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01009",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01014",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Balsalazide is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01250",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Olsalazine is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01283",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Lumiracoxib is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01397",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Magnesium salicylate is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01399",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Salsalate is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01401",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Choline magnesium trisalicylate is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01419",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Antrafenine is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01424",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01435",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01600",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Tiaprofenic acid is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01628",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Etoricoxib is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB02224",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Taxifolin is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB03585",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB04725",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Licofelone is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB04812",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Benoxaprofen is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB04817",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Metamizole is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB04828",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Zomepirac is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB05095",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Cimicoxib is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB06725",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Lornoxicam is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB06736",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Aceclofenac is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB06737",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Zaltoprofen is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB07402",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Azapropazone is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB08439",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Parecoxib is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB08797",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Salicylamide is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB08940",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Kebuzone is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB08942",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Isoxicam is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB08951",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Indoprofen is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB08955",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Ibuproxam is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB08976",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Floctafenine is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB08981",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB08984",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Etofenamate is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB08991",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Epirizole is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB09084",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Benzydamine is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB09214",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Dexketoprofen is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB09215",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Droxicam is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB09216",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Tolfenamic acid is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB09217",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Firocoxib is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB09218",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Clonixin is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB09285",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Morniflumate is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Propacetamol is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB09295",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Talniflumate is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB11455",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Robenacoxib is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB11466",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Tepoxalin is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB11518",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Flunixin is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB12399",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Polmacoxib is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB12610",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Ebselen is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13001",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Tinoridine is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13167",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Alclofenac is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13217",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Fentiazac is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13232",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Suxibuzone is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13286",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Bumadizone is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13314",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Alminoprofen is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13371",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Difenpiramide is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13407",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Nifenazone is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13432",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Lonazolac is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13481",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Tenidap is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13524",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Propyphenazone is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13527",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Proglumetacin is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13538",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Guacetisal is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13544",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Ethenzamide is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13612",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Carbaspirin calcium is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13629",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Mofebutazone is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13649",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Proquazone is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13657",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Benorilate is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13722",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Pirprofen is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13860",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Imidazole salicylate is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB14059",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when SC 236 is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB14060",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when NS 398 is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB14938",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen axetil is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB09212",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Loxoprofen is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB04865",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Omacetaxine mepesuccinate"
                    },
                    {
                        "drugbank-id": "DB11133",
                        "description": "Omega 3 fatty acids may increase the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00081",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Nafamostat is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00048",
                        "description": "The risk or severity of adverse effects can be increased when Nafamostat is combined with Collagenase clostridium histolyticum"
                    },
                    {
                        "drugbank-id": "DB00389",
                        "description": "Carbimazole may increase the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00550",
                        "description": "Propylthiouracil may increase the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00763",
                        "description": "Methimazole may increase the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB03374",
                        "description": "3 5 Diiodotyrosine may increase the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB06715",
                        "description": "Potassium Iodide may increase the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB07637",
                        "description": "Dibromotyrosine may increase the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB09418",
                        "description": "Potassium perchlorate may increase the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13644",
                        "description": "Methylthiouracil may increase the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13804",
                        "description": "Benzylthiouracil may increase the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Mifepristone"
                    },
                    {
                        "drugbank-id": "DB04066",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with p Coumaric acid"
                    },
                    {
                        "drugbank-id": "DB04682",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Octylphenoxy polyethoxyethanol"
                    },
                    {
                        "drugbank-id": "DB05830",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Trestolone"
                    },
                    {
                        "drugbank-id": "DB06266",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Lonidamine"
                    },
                    {
                        "drugbank-id": "DB08867",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Ulipristal"
                    },
                    {
                        "drugbank-id": "DB09401",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Isosorbide"
                    },
                    {
                        "drugbank-id": "DB11507",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cloprostenol"
                    },
                    {
                        "drugbank-id": "DB12025",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Triptolide"
                    },
                    {
                        "drugbank-id": "DB13044",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Gossypol"
                    },
                    {
                        "drugbank-id": "DB13310",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Ormeloxifene"
                    },
                    {
                        "drugbank-id": "DB00396",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Progesterone"
                    },
                    {
                        "drugbank-id": "DB00294",
                        "description": "Etonogestrel may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00304",
                        "description": "Desogestrel may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00351",
                        "description": "Megestrol acetate may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00367",
                        "description": "Levonorgestrel may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00378",
                        "description": "Dydrogesterone may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00603",
                        "description": "Medroxyprogesterone acetate may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00717",
                        "description": "Norethisterone may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00823",
                        "description": "Ethynodiol diacetate may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00957",
                        "description": "Norgestimate may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01395",
                        "description": "Drospirenone may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01431",
                        "description": "Allylestrenol may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB04839",
                        "description": "Cyproterone acetate may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB06713",
                        "description": "Norelgestromin may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB06730",
                        "description": "Gestodene may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB06789",
                        "description": "Hydroxyprogesterone caproate may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB09123",
                        "description": "Dienogest may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB09124",
                        "description": "Medrogestone may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB09371",
                        "description": "Norethynodrel may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB09389",
                        "description": "Norgestrel may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB11372",
                        "description": "Altrenogest may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB11619",
                        "description": "Gestrinone may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB11636",
                        "description": "Nomegestrol may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB12474",
                        "description": "Lynestrenol may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13230",
                        "description": "Gestonorone may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13528",
                        "description": "Chlormadinone may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13533",
                        "description": "Methylestrenolone may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13563",
                        "description": "Norgestrienone may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13602",
                        "description": "Promegestone may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13685",
                        "description": "Quingestanol may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13857",
                        "description": "Demegestone may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13866",
                        "description": "Etynodiol may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13981",
                        "description": "Nomegestrol acetate may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB14570",
                        "description": "Hydroxyprogesterone may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB14678",
                        "description": "Norethindrone enanthate may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB14679",
                        "description": "Quingestanol acetate may decrease the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00233",
                        "description": "The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01294",
                        "description": "The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB06251",
                        "description": "The risk or severity of bleeding can be increased when Dersalazine is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB06807",
                        "description": "The risk or severity of bleeding can be increased when Phenyl aminosalicylate is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB09543",
                        "description": "The risk or severity of bleeding can be increased when Methyl salicylate is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB11079",
                        "description": "The risk or severity of bleeding can be increased when Trolamine salicylate is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13509",
                        "description": "The risk or severity of bleeding can be increased when Aloxiprin is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB14026",
                        "description": "The risk or severity of bleeding can be increased when Thiosalicylic acid is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB14006",
                        "description": "The risk or severity of bleeding can be increased when Choline salicylate is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00054",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00063",
                        "description": "The risk or severity of bleeding can be increased when Eptifibatide is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00208",
                        "description": "The risk or severity of bleeding can be increased when Ticlopidine is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00261",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00758",
                        "description": "The risk or severity of bleeding can be increased when Clopidogrel is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00775",
                        "description": "The risk or severity of bleeding can be increased when Tirofiban is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00975",
                        "description": "The risk or severity of bleeding can be increased when Dipyridamole is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01088",
                        "description": "The risk or severity of bleeding can be increased when Iloprost is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01138",
                        "description": "The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The risk or severity of bleeding can be increased when Cilostazol is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01207",
                        "description": "The risk or severity of bleeding can be increased when Ridogrel is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of bleeding can be increased when Sevoflurane is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01240",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB02709",
                        "description": "The risk or severity of bleeding can be increased when Resveratrol is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB04743",
                        "description": "The risk or severity of bleeding can be increased when Nimesulide is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB04905",
                        "description": "The risk or severity of bleeding can be increased when Tesmilifene is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB04932",
                        "description": "The risk or severity of bleeding can be increased when Defibrotide is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB05229",
                        "description": "The risk or severity of bleeding can be increased when Beraprost is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB05266",
                        "description": "The risk or severity of bleeding can be increased when Ibudilast is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB05767",
                        "description": "The risk or severity of bleeding can be increased when Andrographolide is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB06081",
                        "description": "The risk or severity of bleeding can be increased when Caplacizumab is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB06209",
                        "description": "The risk or severity of bleeding can be increased when Prasugrel is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB06441",
                        "description": "The risk or severity of bleeding can be increased when Cangrelor is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB07615",
                        "description": "The risk or severity of bleeding can be increased when Tranilast is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB08814",
                        "description": "The risk or severity of bleeding can be increased when Triflusal is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB08816",
                        "description": "The risk or severity of bleeding can be increased when Ticagrelor is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB08887",
                        "description": "The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB09283",
                        "description": "The risk or severity of bleeding can be increased when Trapidil is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB12092",
                        "description": "The risk or severity of bleeding can be increased when Naftopidil is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB12163",
                        "description": "The risk or severity of bleeding can be increased when Sarpogrelate is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB12321",
                        "description": "The risk or severity of bleeding can be increased when Ifetroban is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB12445",
                        "description": "The risk or severity of bleeding can be increased when Nitroaspirin is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB12465",
                        "description": "The risk or severity of bleeding can be increased when Ketanserin is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB12545",
                        "description": "The risk or severity of bleeding can be increased when Indobufen is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB12749",
                        "description": "The risk or severity of bleeding can be increased when Butylphthalide is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB12771",
                        "description": "The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13036",
                        "description": "The risk or severity of bleeding can be increased when Ramatroban is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13327",
                        "description": "The risk or severity of bleeding can be increased when Picotamide is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13367",
                        "description": "The risk or severity of bleeding can be increased when Cloricromen is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13400",
                        "description": "The risk or severity of bleeding can be increased when Linsidomine is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13510",
                        "description": "The risk or severity of bleeding can be increased when Buflomedil is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13929",
                        "description": "The risk or severity of bleeding can be increased when Relcovaptan is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00374",
                        "description": "The risk or severity of bleeding can be increased when Treprostinil is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00078",
                        "description": "The risk or severity of adverse effects can be increased when Nafamostat is combined with Ibritumomab tiuxetan"
                    },
                    {
                        "drugbank-id": "DB03404",
                        "description": "Hemin may increase the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13783",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Acemetacin is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00624",
                        "description": "Testosterone may increase the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01420",
                        "description": "Testosterone propionate may increase the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01481",
                        "description": "1 Testosterone may increase the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01485",
                        "description": "4 Hydroxytestosterone may increase the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01510",
                        "description": "Dehydrochloromethyltestosterone may increase the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01541",
                        "description": "Boldenone may increase the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01543",
                        "description": "18 methyl 19 nortestosterone may increase the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01564",
                        "description": "Calusterone may increase the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01569",
                        "description": "Formebolone may increase the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01572",
                        "description": "Methyl 1 testosterone may increase the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB07447",
                        "description": "5beta dihydrotestosterone may increase the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB08619",
                        "description": "Testosterone succinate may increase the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB11429",
                        "description": "Mibolerone may increase the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13943",
                        "description": "Testosterone cypionate may increase the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13944",
                        "description": "Testosterone enanthate may increase the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13946",
                        "description": "Testosterone undecanoate may increase the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13947",
                        "description": "Testosterone enantate benzilic acid hydrazone may increase the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13951",
                        "description": "Stanolone acetate may increase the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13958",
                        "description": "Trestolone acetate may increase the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB14093",
                        "description": "1 2 6 7 3H Testosterone may increase the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB14655",
                        "description": "Drostanolone propionate may increase the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB11051",
                        "description": "The risk or severity of adverse effects can be increased when Nafamostat is combined with Azficel T"
                    },
                    {
                        "drugbank-id": "DB09568",
                        "description": "The therapeutic efficacy of Nafamostat can be increased when used in combination with Omega 3 carboxylic acids"
                    },
                    {
                        "drugbank-id": "DB00025",
                        "description": "The therapeutic efficacy of Antihemophilic factor human recombinant can be decreased when used in combination with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00036",
                        "description": "The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00100",
                        "description": "The therapeutic efficacy of Coagulation Factor IX Recombinant can be decreased when used in combination with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00258",
                        "description": "The therapeutic efficacy of Calcium acetate can be decreased when used in combination with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01164",
                        "description": "The therapeutic efficacy of Calcium chloride can be decreased when used in combination with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01373",
                        "description": "The therapeutic efficacy of Calcium can be decreased when used in combination with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01783",
                        "description": "The therapeutic efficacy of Pantothenic acid can be decreased when used in combination with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01942",
                        "description": "The therapeutic efficacy of Formic acid can be decreased when used in combination with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB02261",
                        "description": "The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB06724",
                        "description": "The therapeutic efficacy of Calcium carbonate can be decreased when used in combination with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB09109",
                        "description": "The therapeutic efficacy of Turoctocog alfa can be decreased when used in combination with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB09222",
                        "description": "The therapeutic efficacy of Fibrinogen human can be decreased when used in combination with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB09310",
                        "description": "The therapeutic efficacy of Catridecacog can be decreased when used in combination with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB09329",
                        "description": "The therapeutic efficacy of Antihemophilic Factor Recombinant PEGylated can be decreased when used in combination with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB11093",
                        "description": "The therapeutic efficacy of Calcium citrate can be decreased when used in combination with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB11126",
                        "description": "The therapeutic efficacy of Calcium gluconate can be decreased when used in combination with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB11168",
                        "description": "The therapeutic efficacy of Calcium threonate can be decreased when used in combination with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB11311",
                        "description": "The therapeutic efficacy of Prothrombin can be decreased when used in combination with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB11330",
                        "description": "The therapeutic efficacy of Factor IX Complex Human can be decreased when used in combination with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB11348",
                        "description": "The therapeutic efficacy of Calcium Phosphate can be decreased when used in combination with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB11606",
                        "description": "The therapeutic efficacy of Susoctocog alfa can be decreased when used in combination with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB11608",
                        "description": "The therapeutic efficacy of Eftrenonacog alfa can be decreased when used in combination with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB11668",
                        "description": "The therapeutic efficacy of Rusalatide acetate can be decreased when used in combination with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB12409",
                        "description": "The therapeutic efficacy of Vatreptacog alfa can be decreased when used in combination with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB12909",
                        "description": "The therapeutic efficacy of Factor XIII human can be decreased when used in combination with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13133",
                        "description": "The therapeutic efficacy of Von Willebrand Factor Human can be decreased when used in combination with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13148",
                        "description": "The therapeutic efficacy of Coagulation factor X human can be decreased when used in combination with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13150",
                        "description": "The therapeutic efficacy of Coagulation factor VII human can be decreased when used in combination with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13151",
                        "description": "The therapeutic efficacy of Anti inhibitor coagulant complex can be decreased when used in combination with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13152",
                        "description": "The therapeutic efficacy of Coagulation Factor IX Human can be decreased when used in combination with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13192",
                        "description": "The therapeutic efficacy of Antihemophilic factor human can be decreased when used in combination with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13197",
                        "description": "The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13201",
                        "description": "The therapeutic efficacy of Trenonacog alfa can be decreased when used in combination with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13884",
                        "description": "The therapeutic efficacy of Albutrepenonacog alfa can be decreased when used in combination with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13923",
                        "description": "The therapeutic efficacy of Emicizumab can be decreased when used in combination with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13933",
                        "description": "The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13999",
                        "description": "The therapeutic efficacy of Moroctocog alfa can be decreased when used in combination with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB14473",
                        "description": "The therapeutic efficacy of Beroctocog alfa can be decreased when used in combination with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB14562",
                        "description": "The therapeutic efficacy of Andexanet alfa can be decreased when used in combination with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB14577",
                        "description": "The therapeutic efficacy of Calcium cation can be decreased when used in combination with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB14700",
                        "description": "The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB14738",
                        "description": "The therapeutic efficacy of Turoctocog alfa pegol can be decreased when used in combination with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00176",
                        "description": "The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The risk or severity of hemorrhage can be increased when Citalopram is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "The risk or severity of hemorrhage can be increased when Fluoxetine is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00715",
                        "description": "The risk or severity of hemorrhage can be increased when Paroxetine is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01149",
                        "description": "The risk or severity of hemorrhage can be increased when Nefazodone is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB04832",
                        "description": "The risk or severity of hemorrhage can be increased when Zimelidine is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB04884",
                        "description": "The risk or severity of hemorrhage can be increased when Dapoxetine is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB06731",
                        "description": "The risk or severity of hemorrhage can be increased when Seproxetine is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB08953",
                        "description": "The risk or severity of hemorrhage can be increased when Indalpine is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB12693",
                        "description": "The risk or severity of hemorrhage can be increased when Ritanserin is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13233",
                        "description": "The risk or severity of hemorrhage can be increased when Alaproclate is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00476",
                        "description": "The risk or severity of hemorrhage can be increased when Duloxetine is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01105",
                        "description": "The risk or severity of hemorrhage can be increased when Sibutramine is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB04896",
                        "description": "The risk or severity of hemorrhage can be increased when Milnacipran is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB06700",
                        "description": "The risk or severity of hemorrhage can be increased when Desvenlafaxine is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB08918",
                        "description": "The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "Venlafaxine may increase the antiplatelet activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00122",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Choline"
                    },
                    {
                        "drugbank-id": "DB00152",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Thiamine"
                    },
                    {
                        "drugbank-id": "DB00184",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Nicotine"
                    },
                    {
                        "drugbank-id": "DB00243",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Ranolazine"
                    },
                    {
                        "drugbank-id": "DB00264",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Metoprolol"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Disopyramide"
                    },
                    {
                        "drugbank-id": "DB00331",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Metformin"
                    },
                    {
                        "drugbank-id": "DB00345",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Aminohippuric acid"
                    },
                    {
                        "drugbank-id": "DB00365",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Grepafloxacin"
                    },
                    {
                        "drugbank-id": "DB00368",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Norepinephrine"
                    },
                    {
                        "drugbank-id": "DB00440",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Trimethoprim"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Imipramine"
                    },
                    {
                        "drugbank-id": "DB00501",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Cimetidine"
                    },
                    {
                        "drugbank-id": "DB00515",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Cisplatin"
                    },
                    {
                        "drugbank-id": "DB00536",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Guanidine"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Lamotrigine"
                    },
                    {
                        "drugbank-id": "DB00571",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Propranolol"
                    },
                    {
                        "drugbank-id": "DB00594",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Amiloride"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Imatinib"
                    },
                    {
                        "drugbank-id": "DB00668",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Epinephrine"
                    },
                    {
                        "drugbank-id": "DB00690",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Flurazepam"
                    },
                    {
                        "drugbank-id": "DB00863",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Ranitidine"
                    },
                    {
                        "drugbank-id": "DB00914",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Phenformin"
                    },
                    {
                        "drugbank-id": "DB00915",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Amantadine"
                    },
                    {
                        "drugbank-id": "DB00917",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Dinoprostone"
                    },
                    {
                        "drugbank-id": "DB00925",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Phenoxybenzamine"
                    },
                    {
                        "drugbank-id": "DB00927",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Famotidine"
                    },
                    {
                        "drugbank-id": "DB00938",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Salmeterol"
                    },
                    {
                        "drugbank-id": "DB00988",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Dopamine"
                    },
                    {
                        "drugbank-id": "DB01032",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Probenecid"
                    },
                    {
                        "drugbank-id": "DB01035",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Procainamide"
                    },
                    {
                        "drugbank-id": "DB01075",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Diphenhydramine"
                    },
                    {
                        "drugbank-id": "DB01103",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Quinacrine"
                    },
                    {
                        "drugbank-id": "DB01114",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Chlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Amiodarone"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Desipramine"
                    },
                    {
                        "drugbank-id": "DB01273",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Varenicline"
                    },
                    {
                        "drugbank-id": "DB01580",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Oxprenolol"
                    },
                    {
                        "drugbank-id": "DB03034",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with D Levofloxacin"
                    },
                    {
                        "drugbank-id": "DB04855",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Dronedarone"
                    },
                    {
                        "drugbank-id": "DB05294",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Vandetanib"
                    },
                    {
                        "drugbank-id": "DB05381",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Histamine"
                    },
                    {
                        "drugbank-id": "DB05383",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Pimagedine"
                    },
                    {
                        "drugbank-id": "DB06608",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Tafenoquine"
                    },
                    {
                        "drugbank-id": "DB08865",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Crizotinib"
                    },
                    {
                        "drugbank-id": "DB08882",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Linagliptin"
                    },
                    {
                        "drugbank-id": "DB08930",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB09078",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Lenvatinib"
                    },
                    {
                        "drugbank-id": "DB09555",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11633",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Isavuconazole"
                    },
                    {
                        "drugbank-id": "DB11652",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Tucatinib"
                    },
                    {
                        "drugbank-id": "DB11817",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Baricitinib"
                    },
                    {
                        "drugbank-id": "DB11901",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Apalutamide"
                    },
                    {
                        "drugbank-id": "DB12147",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Erdafitinib"
                    },
                    {
                        "drugbank-id": "DB13874",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Enasidenib"
                    },
                    {
                        "drugbank-id": "DB13955",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Estradiol dienanthate"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Amphetamine is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00601",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00614",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Furazolidone is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00721",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00752",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00780",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Phenelzine is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00805",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Minaprine is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01037",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01168",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01171",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Moclobemide is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01247",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Isocarboxazid is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01367",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01626",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Pargyline is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB04017",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Clorgiline is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB04818",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Iproniazid is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB04820",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB06654",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB08550",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when 7 8 Dichloro 1 2 3 4 tetrahydroisoquinoline is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Methylene blue is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB09243",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Hydracarbazine is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB09244",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Pirlindole is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB09245",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Toloxatone is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB09246",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Benmoxin is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB09248",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Mebanazine is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB09249",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Octamoxin is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB09250",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Pheniprazine is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB09251",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Phenoxypropazine is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB09252",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Pivhydrazine is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB09253",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Safrazine is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB09254",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Caroxazone is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13875",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Harmaline is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB13876",
                        "description": "The risk or severity of bleeding and hemorrhage can be increased when Brofaromine is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00006",
                        "description": "The risk or severity of bleeding can be increased when Bivalirudin is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00266",
                        "description": "The risk or severity of bleeding can be increased when Dicoumarol is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00278",
                        "description": "The risk or severity of bleeding can be increased when Argatroban is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00407",
                        "description": "The risk or severity of bleeding can be increased when Ardeparin is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00498",
                        "description": "The risk or severity of bleeding can be increased when Phenindione is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00569",
                        "description": "The risk or severity of bleeding can be increased when Fondaparinux is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00682",
                        "description": "The risk or severity of bleeding can be increased when Warfarin is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00946",
                        "description": "The risk or severity of bleeding can be increased when Phenprocoumon is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00974",
                        "description": "The risk or severity of bleeding can be increased when Edetic acid is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01109",
                        "description": "The risk or severity of bleeding can be increased when Heparin is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01225",
                        "description": "The risk or severity of bleeding can be increased when Enoxaparin is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01418",
                        "description": "The risk or severity of bleeding can be increased when Acenocoumarol is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB04898",
                        "description": "The risk or severity of bleeding can be increased when Ximelagatran is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB05099",
                        "description": "The risk or severity of bleeding can be increased when Ancrod is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB06271",
                        "description": "The risk or severity of bleeding can be increased when Sulodexide is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB06406",
                        "description": "The risk or severity of bleeding can be increased when Idraparinux is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB06635",
                        "description": "The risk or severity of bleeding can be increased when Otamixaban is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB06754",
                        "description": "The risk or severity of bleeding can be increased when Danaparoid is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB06779",
                        "description": "The risk or severity of bleeding can be increased when Dalteparin is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB07767",
                        "description": "The risk or severity of bleeding can be increased when Ferulic acid is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB08794",
                        "description": "The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB08813",
                        "description": "The risk or severity of bleeding can be increased when Nadroparin is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB09255",
                        "description": "The risk or severity of bleeding can be increased when Dextran is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB11095",
                        "description": "The risk or severity of bleeding can be increased when Desirudin is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB11268",
                        "description": "The risk or severity of bleeding can be increased when Protocatechualdehyde is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB11312",
                        "description": "The risk or severity of bleeding can be increased when Protein C is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB11598",
                        "description": "The risk or severity of bleeding can be increased when Antithrombin III human is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB11984",
                        "description": "The risk or severity of bleeding can be increased when Letaxaban is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB12289",
                        "description": "The risk or severity of bleeding can be increased when Darexaban is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB12831",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Gabexate"
                    },
                    {
                        "drugbank-id": "DB13124",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Troxerutin"
                    },
                    {
                        "drugbank-id": "DB13136",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Fluindione"
                    },
                    {
                        "drugbank-id": "DB13149",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Protein S human"
                    },
                    {
                        "drugbank-id": "DB13616",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Melagatran"
                    },
                    {
                        "drugbank-id": "DB09125",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Potassium citrate"
                    },
                    {
                        "drugbank-id": "DB09154",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Sodium citrate"
                    },
                    {
                        "drugbank-id": "DB00031",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Tenecteplase"
                    },
                    {
                        "drugbank-id": "DB00055",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Drotrecogin alfa"
                    },
                    {
                        "drugbank-id": "DB06822",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Tinzaparin"
                    },
                    {
                        "drugbank-id": "DB13199",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Brinase"
                    },
                    {
                        "drugbank-id": "DB13646",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Saruplase"
                    },
                    {
                        "drugbank-id": "DB00086",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Streptokinase"
                    },
                    {
                        "drugbank-id": "DB04925",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Desmoteplase"
                    },
                    {
                        "drugbank-id": "DB05254",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Fibrinolysin"
                    },
                    {
                        "drugbank-id": "DB06543",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Astaxanthin"
                    },
                    {
                        "drugbank-id": "DB08994",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Ditazole"
                    },
                    {
                        "drugbank-id": "DB09258",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Bemiparin"
                    },
                    {
                        "drugbank-id": "DB09260",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Parnaparin"
                    },
                    {
                        "drugbank-id": "DB13275",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Clorindione"
                    },
                    {
                        "drugbank-id": "DB13347",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Diphenadione"
                    },
                    {
                        "drugbank-id": "DB13451",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Tioclomarol"
                    },
                    {
                        "drugbank-id": "DB00001",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Lepirudin"
                    },
                    {
                        "drugbank-id": "DB00009",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Alteplase"
                    },
                    {
                        "drugbank-id": "DB00015",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Reteplase"
                    },
                    {
                        "drugbank-id": "DB00029",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Anistreplase"
                    },
                    {
                        "drugbank-id": "DB14094",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Tocopherylquinone"
                    },
                    {
                        "drugbank-id": "DB06679",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Amediplase"
                    },
                    {
                        "drugbank-id": "DB03410",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with 4 hydroxycoumarin"
                    },
                    {
                        "drugbank-id": "DB08496",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with R warfarin"
                    },
                    {
                        "drugbank-id": "DB14055",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with S Warfarin"
                    },
                    {
                        "drugbank-id": "DB12364",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Betrixaban"
                    },
                    {
                        "drugbank-id": "DB14598",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Edetate calcium disodium anhydrous"
                    },
                    {
                        "drugbank-id": "DB11154",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Zinc citrate"
                    },
                    {
                        "drugbank-id": "DB11166",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Antithrombin Alfa"
                    },
                    {
                        "drugbank-id": "DB04665",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Coumarin"
                    },
                    {
                        "drugbank-id": "DB14726",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Dabigatran"
                    },
                    {
                        "drugbank-id": "DB06294",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Semuloparin"
                    },
                    {
                        "drugbank-id": "DB12726",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Monteplase"
                    },
                    {
                        "drugbank-id": "DB09259",
                        "description": "The risk or severity of bleeding can be increased when Reviparin is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00203",
                        "description": "The risk or severity of hemorrhage can be increased when Nafamostat is combined with Sildenafil"
                    },
                    {
                        "drugbank-id": "DB00008",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Peginterferon alfa 2a"
                    },
                    {
                        "drugbank-id": "DB00011",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Interferon alfa n1"
                    },
                    {
                        "drugbank-id": "DB00018",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Interferon alfa n3"
                    },
                    {
                        "drugbank-id": "DB00022",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Peginterferon alfa 2b"
                    },
                    {
                        "drugbank-id": "DB00033",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Interferon gamma 1b"
                    },
                    {
                        "drugbank-id": "DB00034",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Interferon alfa 2a Recombinant"
                    },
                    {
                        "drugbank-id": "DB00041",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Aldesleukin"
                    },
                    {
                        "drugbank-id": "DB00056",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Gemtuzumab ozogamicin"
                    },
                    {
                        "drugbank-id": "DB00068",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Interferon beta 1b"
                    },
                    {
                        "drugbank-id": "DB00069",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Interferon alfacon 1"
                    },
                    {
                        "drugbank-id": "DB00073",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Rituximab"
                    },
                    {
                        "drugbank-id": "DB00087",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Alemtuzumab"
                    },
                    {
                        "drugbank-id": "DB00105",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Interferon alfa 2b"
                    },
                    {
                        "drugbank-id": "DB00120",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Phenylalanine"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Bortezomib"
                    },
                    {
                        "drugbank-id": "DB00242",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Cladribine"
                    },
                    {
                        "drugbank-id": "DB00262",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Carmustine"
                    },
                    {
                        "drugbank-id": "DB00276",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Amsacrine"
                    },
                    {
                        "drugbank-id": "DB00291",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Chlorambucil"
                    },
                    {
                        "drugbank-id": "DB00293",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Raltitrexed"
                    },
                    {
                        "drugbank-id": "DB00305",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Mitomycin"
                    },
                    {
                        "drugbank-id": "DB00307",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Bexarotene"
                    },
                    {
                        "drugbank-id": "DB00309",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Vindesine"
                    },
                    {
                        "drugbank-id": "DB00322",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Floxuridine"
                    },
                    {
                        "drugbank-id": "DB00352",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Tioguanine"
                    },
                    {
                        "drugbank-id": "DB00361",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Vinorelbine"
                    },
                    {
                        "drugbank-id": "DB00380",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Dexrazoxane"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Sorafenib"
                    },
                    {
                        "drugbank-id": "DB00428",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Streptozocin"
                    },
                    {
                        "drugbank-id": "DB00441",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Gemcitabine"
                    },
                    {
                        "drugbank-id": "DB00444",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Teniposide"
                    },
                    {
                        "drugbank-id": "DB00445",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Epirubicin"
                    },
                    {
                        "drugbank-id": "DB00446",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Chloramphenicol"
                    },
                    {
                        "drugbank-id": "DB00480",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Lenalidomide"
                    },
                    {
                        "drugbank-id": "DB00488",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Altretamine"
                    },
                    {
                        "drugbank-id": "DB00495",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Zidovudine"
                    },
                    {
                        "drugbank-id": "DB00526",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Oxaliplatin"
                    },
                    {
                        "drugbank-id": "DB00531",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Cyclophosphamide"
                    },
                    {
                        "drugbank-id": "DB00544",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Fluorouracil"
                    },
                    {
                        "drugbank-id": "DB00552",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Pentostatin"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Methotrexate"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Carbamazepine"
                    },
                    {
                        "drugbank-id": "DB00570",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Vinblastine"
                    },
                    {
                        "drugbank-id": "DB00631",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Clofarabine"
                    },
                    {
                        "drugbank-id": "DB00642",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Pemetrexed"
                    },
                    {
                        "drugbank-id": "DB00694",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Daunorubicin"
                    },
                    {
                        "drugbank-id": "DB00762",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Irinotecan"
                    },
                    {
                        "drugbank-id": "DB00773",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Etoposide"
                    },
                    {
                        "drugbank-id": "DB00851",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Dacarbazine"
                    },
                    {
                        "drugbank-id": "DB00853",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Temozolomide"
                    },
                    {
                        "drugbank-id": "DB00859",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Penicillamine"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Tacrolimus"
                    },
                    {
                        "drugbank-id": "DB00877",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Sirolimus"
                    },
                    {
                        "drugbank-id": "DB00888",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Mechlorethamine"
                    },
                    {
                        "drugbank-id": "DB00928",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Azacitidine"
                    },
                    {
                        "drugbank-id": "DB00958",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Carboplatin"
                    },
                    {
                        "drugbank-id": "DB00970",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Dactinomycin"
                    },
                    {
                        "drugbank-id": "DB00987",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Cytarabine"
                    },
                    {
                        "drugbank-id": "DB00997",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Doxorubicin"
                    },
                    {
                        "drugbank-id": "DB01005",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Hydroxyurea"
                    },
                    {
                        "drugbank-id": "DB01008",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Busulfan"
                    },
                    {
                        "drugbank-id": "DB01030",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Topotecan"
                    },
                    {
                        "drugbank-id": "DB01033",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Mercaptopurine"
                    },
                    {
                        "drugbank-id": "DB01041",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Thalidomide"
                    },
                    {
                        "drugbank-id": "DB01042",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Melphalan"
                    },
                    {
                        "drugbank-id": "DB01073",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Fludarabine"
                    },
                    {
                        "drugbank-id": "DB01099",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Flucytosine"
                    },
                    {
                        "drugbank-id": "DB01101",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Capecitabine"
                    },
                    {
                        "drugbank-id": "DB01169",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Arsenic trioxide"
                    },
                    {
                        "drugbank-id": "DB01177",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Idarubicin"
                    },
                    {
                        "drugbank-id": "DB01204",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01206",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Lomustine"
                    },
                    {
                        "drugbank-id": "DB01229",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Paclitaxel"
                    },
                    {
                        "drugbank-id": "DB01248",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Docetaxel"
                    },
                    {
                        "drugbank-id": "DB01262",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Decitabine"
                    },
                    {
                        "drugbank-id": "DB01280",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Nelarabine"
                    },
                    {
                        "drugbank-id": "DB01590",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Everolimus"
                    },
                    {
                        "drugbank-id": "DB02546",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Vorinostat"
                    },
                    {
                        "drugbank-id": "DB04572",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Thiotepa"
                    },
                    {
                        "drugbank-id": "DB04845",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Ixabepilone"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Nilotinib"
                    },
                    {
                        "drugbank-id": "DB05015",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Belinostat"
                    },
                    {
                        "drugbank-id": "DB05109",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Trabectedin"
                    },
                    {
                        "drugbank-id": "DB05258",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Interferon alfa"
                    },
                    {
                        "drugbank-id": "DB05472",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Human interferon omega 1"
                    },
                    {
                        "drugbank-id": "DB05773",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Trastuzumab emtansine"
                    },
                    {
                        "drugbank-id": "DB06287",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Temsirolimus"
                    },
                    {
                        "drugbank-id": "DB06616",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Bosutinib"
                    },
                    {
                        "drugbank-id": "DB06769",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Bendamustine"
                    },
                    {
                        "drugbank-id": "DB06772",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Cabazitaxel"
                    },
                    {
                        "drugbank-id": "DB08871",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Eribulin"
                    },
                    {
                        "drugbank-id": "DB08877",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Ruxolitinib"
                    },
                    {
                        "drugbank-id": "DB08889",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Carfilzomib"
                    },
                    {
                        "drugbank-id": "DB08895",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Tofacitinib"
                    },
                    {
                        "drugbank-id": "DB08901",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Ponatinib"
                    },
                    {
                        "drugbank-id": "DB08910",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB09042",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Tedizolid phosphate"
                    },
                    {
                        "drugbank-id": "DB09052",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Blinatumomab"
                    },
                    {
                        "drugbank-id": "DB09074",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Olaparib"
                    },
                    {
                        "drugbank-id": "DB09077",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Dinutuximab"
                    },
                    {
                        "drugbank-id": "DB09122",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Peginterferon beta 1a"
                    },
                    {
                        "drugbank-id": "DB12814",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Cepeginterferon alfa 2B"
                    },
                    {
                        "drugbank-id": "DB00206",
                        "description": "The risk or severity of adverse effects can be increased when Reserpine is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00220",
                        "description": "The risk or severity of adverse effects can be increased when Nelfinavir is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00224",
                        "description": "The risk or severity of adverse effects can be increased when Indinavir is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00238",
                        "description": "The risk or severity of adverse effects can be increased when Nevirapine is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00318",
                        "description": "The risk or severity of adverse effects can be increased when Codeine is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00457",
                        "description": "The risk or severity of adverse effects can be increased when Prazosin is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00590",
                        "description": "The risk or severity of adverse effects can be increased when Doxazosin is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00625",
                        "description": "The risk or severity of adverse effects can be increased when Efavirenz is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00661",
                        "description": "The risk or severity of adverse effects can be increased when Verapamil is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00728",
                        "description": "The risk or severity of adverse effects can be increased when Rocuronium is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00787",
                        "description": "The risk or severity of adverse effects can be increased when Acyclovir is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01004",
                        "description": "The risk or severity of adverse effects can be increased when Ganciclovir is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "The risk or severity of adverse effects can be increased when Saquinavir is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01337",
                        "description": "The risk or severity of adverse effects can be increased when Pancuronium is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB09073",
                        "description": "The risk or severity of adverse effects can be increased when Palbociclib is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB11642",
                        "description": "The risk or severity of adverse effects can be increased when Pitolisant is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB11963",
                        "description": "The risk or severity of adverse effects can be increased when Dacomitinib is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB12141",
                        "description": "The risk or severity of adverse effects can be increased when Gilteritinib is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB12332",
                        "description": "The risk or severity of adverse effects can be increased when Rucaparib is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00983",
                        "description": "The risk or severity of adverse effects can be increased when Formoterol is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01018",
                        "description": "The risk or severity of adverse effects can be increased when Guanfacine is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00229",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefotiam"
                    },
                    {
                        "drugbank-id": "DB00267",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefmenoxime"
                    },
                    {
                        "drugbank-id": "DB00274",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefmetazole"
                    },
                    {
                        "drugbank-id": "DB00430",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefpiramide"
                    },
                    {
                        "drugbank-id": "DB00438",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Ceftazidime"
                    },
                    {
                        "drugbank-id": "DB00447",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Loracarbef"
                    },
                    {
                        "drugbank-id": "DB00456",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefalotin"
                    },
                    {
                        "drugbank-id": "DB00493",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefotaxime"
                    },
                    {
                        "drugbank-id": "DB00535",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefdinir"
                    },
                    {
                        "drugbank-id": "DB00567",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cephalexin"
                    },
                    {
                        "drugbank-id": "DB00671",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefixime"
                    },
                    {
                        "drugbank-id": "DB00689",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cephaloglycin"
                    },
                    {
                        "drugbank-id": "DB00833",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefaclor"
                    },
                    {
                        "drugbank-id": "DB00923",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Ceforanide"
                    },
                    {
                        "drugbank-id": "DB01066",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefditoren"
                    },
                    {
                        "drugbank-id": "DB01112",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefuroxime"
                    },
                    {
                        "drugbank-id": "DB01139",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefapirin"
                    },
                    {
                        "drugbank-id": "DB01140",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefadroxil"
                    },
                    {
                        "drugbank-id": "DB01150",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefprozil"
                    },
                    {
                        "drugbank-id": "DB01212",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Ceftriaxone"
                    },
                    {
                        "drugbank-id": "DB01326",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefamandole"
                    },
                    {
                        "drugbank-id": "DB01327",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefazolin"
                    },
                    {
                        "drugbank-id": "DB01328",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefonicid"
                    },
                    {
                        "drugbank-id": "DB01329",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefoperazone"
                    },
                    {
                        "drugbank-id": "DB01330",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefotetan"
                    },
                    {
                        "drugbank-id": "DB01331",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefoxitin"
                    },
                    {
                        "drugbank-id": "DB01332",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Ceftizoxime"
                    },
                    {
                        "drugbank-id": "DB01333",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefradine"
                    },
                    {
                        "drugbank-id": "DB01413",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefepime"
                    },
                    {
                        "drugbank-id": "DB01414",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefacetrile"
                    },
                    {
                        "drugbank-id": "DB01415",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Ceftibuten"
                    },
                    {
                        "drugbank-id": "DB01416",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefpodoxime"
                    },
                    {
                        "drugbank-id": "DB04570",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Latamoxef"
                    },
                    {
                        "drugbank-id": "DB04918",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Ceftobiprole"
                    },
                    {
                        "drugbank-id": "DB06590",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Ceftaroline fosamil"
                    },
                    {
                        "drugbank-id": "DB09008",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefaloridine"
                    },
                    {
                        "drugbank-id": "DB09050",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Ceftolozane"
                    },
                    {
                        "drugbank-id": "DB09062",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefminox"
                    },
                    {
                        "drugbank-id": "DB11367",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefroxadine"
                    },
                    {
                        "drugbank-id": "DB11935",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Flomoxef"
                    },
                    {
                        "drugbank-id": "DB13266",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefatrizine"
                    },
                    {
                        "drugbank-id": "DB13461",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefcapene"
                    },
                    {
                        "drugbank-id": "DB13470",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefodizime"
                    },
                    {
                        "drugbank-id": "DB13499",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefsulodin"
                    },
                    {
                        "drugbank-id": "DB13504",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefetamet"
                    },
                    {
                        "drugbank-id": "DB13638",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefbuperazone"
                    },
                    {
                        "drugbank-id": "DB13667",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefozopran"
                    },
                    {
                        "drugbank-id": "DB13682",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefpirome"
                    },
                    {
                        "drugbank-id": "DB13778",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefazedone"
                    },
                    {
                        "drugbank-id": "DB13821",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Ceftezole"
                    },
                    {
                        "drugbank-id": "DB14725",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefamandole nafate"
                    },
                    {
                        "drugbank-id": "DB00254",
                        "description": "The risk or severity of bleeding can be increased when Doxycycline is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00207",
                        "description": "The risk or severity of adverse effects can be increased when Azithromycin is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB09539",
                        "description": "The risk or severity of bleeding can be increased when Omega 3 acid ethyl esters is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00945",
                        "description": "Acetylsalicylic acid may increase the anticoagulant activities of Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01606",
                        "description": "The risk or severity of bleeding can be increased when Tazobactam is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00199",
                        "description": "The risk or severity of bleeding can be increased when Erythromycin is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00656",
                        "description": "The risk or severity of bleeding can be increased when Trazodone is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00620",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Triamcinolone"
                    },
                    {
                        "drugbank-id": "DB09079",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Nintedanib"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The risk or severity of bleeding can be increased when Escitalopram is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB01104",
                        "description": "The risk or severity of bleeding can be increased when Sertraline is combined with Nafamostat"
                    },
                    {
                        "drugbank-id": "DB00232",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Methyclothiazide"
                    },
                    {
                        "drugbank-id": "DB00436",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Bendroflumethiazide"
                    },
                    {
                        "drugbank-id": "DB00562",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Benzthiazide"
                    },
                    {
                        "drugbank-id": "DB00606",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cyclothiazide"
                    },
                    {
                        "drugbank-id": "DB00774",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Hydroflumethiazide"
                    },
                    {
                        "drugbank-id": "DB00880",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Chlorothiazide"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Hydrochlorothiazide"
                    },
                    {
                        "drugbank-id": "DB01021",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Trichlormethiazide"
                    },
                    {
                        "drugbank-id": "DB01324",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Polythiazide"
                    },
                    {
                        "drugbank-id": "DB13430",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Mebutizide"
                    },
                    {
                        "drugbank-id": "DB13532",
                        "description": "The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cyclopenthiazide"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}